Organon And Henlius Advance Perjeta Biosimilar

Partners Publicize Progress On Pertuzumab Product With Positive Phase III Payoff

 
• By Dave Wallace
  
Pertuzumab with mab symbol
Henlius and Organon’s pertuzumab met the Phase III primary endpoint • Source: Shutterstock

More from Biosimilars

More from Products